Ustekinumab 45MG/0.5ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F0Y6Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,851
Award facts
- Contract value 100% obligated
- $7,850.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on July 13, 2026, for Ustekinumab 45mg/0.5mL syringes with a ceiling value of $7,850.52 and an ultimate completion date of August 3, 2026.
Place of performance is Conshohocken, PA. The order is issued as firm fixed price under the DLA Troop Support Medical SPE2DX indefinite delivery contract, which supports pharmaceutical supply to military healthcare systems globally. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26F0Y6Y?
SPE2DR26F0Y6Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 13, 2026.
How much is contract SPE2DR26F0Y6Y worth?
The government has obligated $7,851 on SPE2DR26F0Y6Y.
Is contract SPE2DR26F0Y6Y an order under another contract?
Yes. SPE2DR26F0Y6Y is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0Y6Y competed?
The extent of competition for SPE2DR26F0Y6Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award